Prostate lineage-specific metabolism governs luminal differentiation and response to antiandrogen treatment

前列腺谱系特异性代谢调控管腔分化和对抗雄激素治疗的反应

阅读:5
作者:Jenna M Giafaglione ,Preston D Crowell ,Amelie M L Delcourt ,Takao Hashimoto ,Sung Min Ha ,Aishwarya Atmakuri ,Nicholas M Nunley ,Rachel M A Dang ,Mao Tian ,Johnny A Diaz ,Elisavet Tika ,Marie C Payne ,Deborah L Burkhart ,Dapei Li ,Nora M Navone ,Eva Corey ,Peter S Nelson ,Neil Y C Lin ,Cedric Blanpain ,Leigh Ellis ,Paul C Boutros ,Andrew S Goldstein

Abstract

Lineage transitions are a central feature of prostate development, tumourigenesis and treatment resistance. While epigenetic changes are well known to drive prostate lineage transitions, it remains unclear how upstream metabolic signalling contributes to the regulation of prostate epithelial identity. To fill this gap, we developed an approach to perform metabolomics on primary prostate epithelial cells. Using this approach, we discovered that the basal and luminal cells of the prostate exhibit distinct metabolomes and nutrient utilization patterns. Furthermore, basal-to-luminal differentiation is accompanied by increased pyruvate oxidation. We establish the mitochondrial pyruvate carrier and subsequent lactate accumulation as regulators of prostate luminal identity. Inhibition of the mitochondrial pyruvate carrier or supplementation with exogenous lactate results in large-scale chromatin remodelling, influencing both lineage-specific transcription factors and response to antiandrogen treatment. These results establish reciprocal regulation of metabolism and prostate epithelial lineage identity.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。